Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening.
Ontology highlight
ABSTRACT: O-GlcNAcylation is an essential post-translational modification installed by the enzyme O-β-N-acetyl-d-glucosaminyl transferase (OGT). Modulating this enzyme would be extremely valuable to better understand its role in the development of serious human pathologies, such as diabetes and cancer. However, the limited availability of potent and selective inhibitors hinders the validation of this potential therapeutic target. To explore new chemotypes that target the active site of OGT, we performed virtual screening of a large library of commercially available compounds with drug-like properties. We purchased samples of the most promising virtual hits and used enzyme assays to identify authentic leads. Structure-activity relationships of the best identified OGT inhibitor we
SUBMITTER: Loi EM
PROVIDER: S-EPMC8950328 | biostudies-literature | 2022 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA